Breaking News
Sort by:
Top Post
Roche Introduces Cobas Infinity Edge, a New Open Digital Ecosystem for Point of Care Professionals, Driving Improved Patient Outcomes and Operational Efficiencies in Healthcare
Roche (SIX: RO, ROG; OTCQX: RHHBY) today introduced cobas ® infinity edge, a secure and […]
PerkinElmer Signals Research™ Suite Platform Integrates Scientific Data Silos and Enhances Collaboration for R&D Teams
PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the […]
Anomaly Raises $17 Million to Scale Precision Payments Platform Across Healthcare Industry
Anomaly, a precision payments platform using artificial intelligence (AI) to improve payment accuracy in the […]
Evonetix Granted Patent for DNA Data Storage and Retrieval Method
EVONETIX LTD (‘Evonetix’), the synthetic biology company developing a desktop platform for scalable, high-fidelity and […]
Holmusk Signs Agreements with UTHealth and The Harris Center
Holmusk, a leading global data science and health technology company building the world’s largest Real-World […]
Olive Adopts AWS as its Preferred Cloud Provider to Create the Internet of Healthcare
Olive, the automation company creating the Internet of Healthcare, announced a strategic relationship today with […]
The Chinese University of Hong Kong and ConsenSys Announce the Medoxie COVID-19 Digital Health Passport
The Chinese University of Hong Kong (CUHK) along with ConsenSys, the leading Ethereum software company, […]
Nearly Half of All Clinical Research Will Adopt Decentralized Clinical Trials Within Next Twelve Months, Survey Finds
VivaLNK, a leading provider of connected healthcare solutions, today announces the results of a survey of pharma, […]
Syneos Health Partners with Medable, Expanding Decentralized Solutions to Bring Clinical Trials Closer to the Patient
Syneos Health®, the only fully integrated biopharmaceutical solutions organization, and Medable, the leading cloud platform […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more